Pharm Exec's latest survey of press issues shows that media coverage continues to remain on balance negative toward the industry, by a slight margin: 47% this year compared to a 46% average over the last seven years.
Big Pharma takes a fresh licking in our latest audit of US press coverage of business and policy issues.
Our annual press audit finds that the big news in 2011 for pharma was ... no news.
Negative views regarding pharma are on the rise, but vaccines help keep the focus on the positives of innovation
Pricing, promotion, and the unfinished story of healthcare reform dominated the news last year.
Reporters pass on the typical litany of lightning-rod issues and instead devote more than three-quarters of all coverage in 2008 to drug safety—and the regulators who enforce it.
Pharma gets less ink as news reporters shift their sights to other topics? That's a good thing--Isn't it?
And while reporters aren't writing any more about the industry, the topics they cover are a moving target.
The good news is that America's top newspapers were fairer to pharma in 2006. But coverage remains largely negative—and the hot topics are catching the industry by suprise.
How Digital Medicine Can Pinpoint Dosing Regimens to Optimize Drug Efficacy and Safety
Sponsored By Oracle
Multi-faceted Approaches to Meet Payer and Regulatory Evidence Requirements
Sponsored By UBC Express Scripts
Overcoming the Life Sciences Content Conundrum in a Multichannel World
Sponsored By Veeva